Medicare Enrolled

Dr. Aimee Garza, MD

Neurology · Frisco, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
7000 PARKWOOD BLVD, Frisco, TX 75034
2144944424
Registered in NPPES since 2007
NPI: 1487854667 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garza

Dr. Aimee Garza is a neurology specialist in Frisco, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Garza performed 283 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Garza received a total of $181,880 from 116 pharmaceutical and/or device companies across 2232 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 283 Medicare services $181,880 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
283
Medicare services
Bottom 36% in TX for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
211 $80 $221
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $105 $221
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
23 $71 $125
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $40 $221
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$181,880
Total received (2018-2024)
Avg $25,983/year across 7 years
Top 4% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
116
Companies
2,232
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,270
2023
$10,880
2022
$53,607
2021
$34,039
2020
$28,837
2019
$19,559
2018
$21,687

Payments by company (2024)

ABBVIE INC.
$6,351
EMD Serono, Inc.
$634
Biogen, Inc.
$482
Genentech USA, Inc.
$388
UCB, Inc.
$372
EDW Pharma, Inc.
$343
PFIZER INC.
$331
Teva Pharmaceuticals USA, Inc.
$320
ARGENX US, INC.
$284
Eisai Inc.
$258
MDD US Operations, LLC
$253
SK Life Science, Inc.
$253
Lundbeck LLC
$243
Novartis Pharmaceuticals Corporation
$197
SCILEX PHARMACEUTICALS INC.
$195
GENZYME CORPORATION
$189
Celgene Corporation
$184
Axsome Therapeutics, Inc.
$169
Neurocrine Biosciences, Inc.
$159
Lilly USA, LLC
$132
E.R. Squibb & Sons, L.L.C.
$129
IDORSIA PHARMACEUTICALS US INC
$119
Neurelis, Inc.
$112
ACADIA Pharmaceuticals Inc
$101
Grifols USA, LLC
$88
MITSUBISHI TANABE PHARMA AMERICA, INC.
$85
Tonix Medicines, Inc.
$83
Amgen Inc.
$70
Abbott Laboratories
$66
HARMONY BIOSCIENCES LLC
$60
Cycle Pharmaceuticals Inc
$59
Takeda Pharmaceuticals U.S.A., Inc.
$53
Alexion Pharmaceuticals, Inc.
$48
Acorda Therapeutics, Inc
$48
Otsuka America Pharmaceutical, Inc.
$41
Mallinckrodt Hospital Products Inc.
$40
TG Therapeutics, Inc.
$39
JAZZ PHARMACEUTICALS INC.
$33
Sandoz Inc.
$29
Kyowa Kirin, Inc.
$28
Aucta Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$27
Merz Pharmaceuticals, LLC
$26
Amneal Pharmaceuticals LLC
$25
Alnylam Pharmaceuticals Inc.
$23
REVANCE THERAPEUTICS, INC.
$21
AstraZeneca Pharmaceuticals LP
$19
CSL Behring
$17
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$51,574
ABBVIE INC.
$28,031
IMPEL PHARMACEUTICALS INC.
$17,525
Allergan, Inc.
$14,470
Promius Pharma LLC
$12,870
Novartis Pharmaceuticals Corporation
$6,376
Biohaven Pharmaceuticals, Inc.
$5,932
AbbVie Inc.
$5,079
Banner Life Sciences, LLC
$5,016
EMD Serono, Inc.
$3,118
Biohaven Pharmaceutical Holding Company Ltd.
$3,116
Biogen, Inc.
$2,693
LivaNova USA, Inc.
$1,818
UCB, Inc.
$1,436
Supernus Pharmaceuticals, Inc.
$1,238
GENZYME CORPORATION
$1,186
Amgen Inc.
$1,144
Genentech USA, Inc.
$1,019
Neurocrine Biosciences, Inc.
$970
Lilly USA, LLC
$862
PFIZER INC.
$809
Eisai Inc.
$712
SK Life Science, Inc.
$705
ACADIA Pharmaceuticals Inc
$646
Lundbeck LLC
$645
Allergan Inc.
$640
Avanir Pharmaceuticals, Inc.
$523
ARGENX US, INC.
$511
Grifols USA, LLC
$459
UPSHER-SMITH LABORATORIES LLC
$425
Alexion Pharmaceuticals, Inc.
$416
CSL Behring
$416
Acorda Therapeutics, Inc
$414
Upsher-Smith Laboratories LLC
$398
Celgene Corporation
$381
MITSUBISHI TANABE PHARMA AMERICA, INC.
$367
Janssen Pharmaceuticals, Inc
$351
AbbVie, Inc.
$351
EDW Pharma, Inc.
$343
Adamas Pharmaceuticals, Inc.
$338
Axsome Therapeutics, Inc.
$312
Amneal Pharmaceuticals LLC
$302
Abbott Laboratories
$268
MDD US Operations, LLC
$253
Alnylam Pharmaceuticals Inc.
$233
Kyowa Kirin, Inc.
$232
SCILEX PHARMACEUTICALS INC.
$231
JAZZ PHARMACEUTICALS INC.
$217
Neurelis, Inc.
$202
Merz Pharmaceuticals, LLC
$185
Assertio Therapeutics, Inc.
$183
Takeda Pharmaceuticals U.S.A., Inc.
$179
MERZ NORTH AMERICA, INC.
$173
Novo Nordisk Inc
$151
E.R. Squibb & Sons, L.L.C.
$141
EISAI INC.
$141
Sunovion Pharmaceuticals Inc.
$139
ASSERTIO THERAPEUTICS, Inc.
$136
US WorldMeds, LLC
$127
Penumbra, Inc.
$121
Mitsubishi Tanabe Pharma America, Inc.
$119
IDORSIA PHARMACEUTICALS US INC
$119
Corium, LLC
$104
Harmony Biosciences LLC
$95
Horizon Therapeutics plc
$94
Bausch Health US, LLC
$84
Aprecia Pharmaceuticals, LLC
$84
Tonix Medicines, Inc.
$83
Strongbridge US INC.
$77
ARBOR PHARMACEUTICALS, INC.
$72
AQUESTIVE THERAPEUTICS, INC.
$71
Mallinckrodt Enterprises LLC
$71
Xeris Pharmaceuticals, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$65
CATALYST PHARMACEUTICALS, INC.
$63
Currax Pharmaceuticals LLC
$61
HARMONY BIOSCIENCES LLC
$60
Cycle Pharmaceuticals Inc
$59
Boston Scientific Corporation
$58
Otsuka America Pharmaceutical, Inc.
$57
Scilex Pharmaceuticals Inc.
$57
Collegium Pharmaceutical, Inc.
$57
Mallinckrodt Hospital Products Inc.
$56
Avion Pharmaceuticals
$54
Octapharma USA, Inc.
$46
Arbor Pharmaceuticals, Inc.
$44
Azurity Pharmaceuticals, Inc.
$43
Pernix Therapeutics Holdings, Inc.
$40
Impax Laboratories, Inc.
$40
TG Therapeutics, Inc.
$39
Jazz Pharmaceuticals Inc.
$36
AngioDynamics, Inc.
$35
Vertical Pharmaceuticals, LLC
$32
Almatica Pharma LLC
$30
Sandoz Inc.
$29
TerSera Therapeutics LLC
$28
Medtronic, Inc.
$28
Aucta Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$27
Exeltis, USA Inc.
$26
BANNER LIFE SCIENCES, LLC
$25
NS Pharma, Inc.
$23
Alfasigma USA, Inc.
$22
Piramal Imaging Limited
$21
GE Healthcare
$21
REVANCE THERAPEUTICS, INC.
$21
Merck Sharp & Dohme Corporation
$19
AstraZeneca Pharmaceuticals LP
$19
Zyla Life Sciences
$18
Medtronic USA, Inc.
$18
Saol Therapeutics Inc.
$17
GE HealthCare
$17
Endo Pharmaceuticals Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Merz North America, Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 53.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · Axium INS DRG IPG · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONFIRM RX · COPAXONE · Cambia · Cenobamate · Confirm Rx · DAXXIFY · DAYBUE · DUEXIS · DUOPA · DYSPORT · Dayvigo · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · JARDIANCE · KESIMPTA · KEVEYIS · LEMTRADA · LORZONE · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAPRELAN · NASCOBAL · NEURACEQ · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ongentys · Ozempic · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Penumbra System · Ponvory · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SILENOR · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Tiglutik · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VECTRIS · VERCISE · VILTEPSO · VIMOVO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · Xadago · Xembify · Xeomin · Xermelo · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZOHYDRO ER · ZOMIG · ZTLido · Zembrace · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Frisco?
Compare neurologists in the Frisco area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
217
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER - FRISCO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Garza is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Garza experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Garza performed 211 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Garza receive payments from pharmaceutical companies?
Yes. Dr. Garza received a total of $181,880 from 116 companies across 2,232 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garza's costs compare to other neurologists in Frisco?
Dr. Garza's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →